Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Samsung Biologics | Seoul | Healthcare | Pharmaceuticals | KRW 71.6T | 66.7x | 5.15 | KRW 1,000,000 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 25.2% Upside | Upgrade to Pro+ | |
Alteogen | KOSDAQ | Healthcare | Pharmaceuticals | KRW 16.47T | -4,279.7x | 36.56 | KRW 309,500 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Yuhan | Seoul | Healthcare | Pharmaceuticals | KRW 9.96T | 52.3x | 0.57 | KRW 134,000 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -4.5% Downside | Upgrade to Pro+ | |
Yuhan | Seoul | Healthcare | Pharmaceuticals | KRW 9.96T | 52.3x | 0.57 | KRW 121,200 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sk Biopharma | Seoul | Healthcare | Pharmaceuticals | KRW 9.17T | 144.5x | 0.88 | KRW 115,100 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.7% Upside | Upgrade to Pro+ | |
SK Bioscience Co | Seoul | Healthcare | Pharmaceuticals | KRW 4.15T | -101.7x | 0.46 | KRW 51,200 | -3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -8.5% Downside | Upgrade to Pro+ | |
Sam Chun Dang Pharm | KOSDAQ | Healthcare | Pharmaceuticals | KRW 3.95T | 663.7x | 5.34 | KRW 160,800 | -5.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hanmi Pharm Co | Seoul | Healthcare | Pharmaceuticals | KRW 3.6T | 21.3x | 0.99 | KRW 271,000 | -4.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 47.9% Upside | Upgrade to Pro+ | |
Hugel | KOSDAQ | Healthcare | Pharmaceuticals | KRW 2.91T | 28.3x | 0.55 | KRW 260,000 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 38.6% Upside | Upgrade to Pro+ | |
Pharma Reaserch Products | KOSDAQ | Healthcare | Pharmaceuticals | KRW 2.61T | 30.4x | 1.2 | KRW 251,000 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.7% Upside | Upgrade to Pro+ | |
Celltrion Pharm | KOSDAQ | Healthcare | Pharmaceuticals | KRW 2.51T | 95.3x | KRW 56,900 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Hanall Biopharma | Seoul | Healthcare | Pharmaceuticals | KRW 2.11T | -272.1x | 1.58 | KRW 41,050 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 25.2% Upside | Upgrade to Pro+ | |
Hanmi Science | Seoul | Healthcare | Pharmaceuticals | KRW 1.98T | 19.3x | 10.25 | KRW 28,950 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
GC Biopharma | Seoul | Healthcare | Pharmaceuticals | KRW 1.92T | -102.5x | 0.09 | KRW 166,000 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.9% Upside | Upgrade to Pro+ | |
ST Pharm | KOSDAQ | Healthcare | Pharmaceuticals | KRW 1.9T | 49.5x | 0.32 | KRW 93,000 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 38% Upside | Upgrade to Pro+ | |
Daewoong Pharma | Seoul | Healthcare | Pharmaceuticals | KRW 1.53T | 13.1x | 0.12 | KRW 130,600 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Caregen | KOSDAQ | Healthcare | Pharmaceuticals | KRW 1.52T | 33.4x | -10.38 | KRW 30,000 | -3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 22.6% Upside | Upgrade to Pro+ | |
Nature Cell | KOSDAQ | Healthcare | Pharmaceuticals | KRW 1.35T | -258.4x | 0.38 | KRW 20,750 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
HLB Life Science | KOSDAQ | Healthcare | Pharmaceuticals | KRW 1.29T | 14.6x | 0.09 | KRW 10,650 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Chong Kun Dang Pharma | Seoul | Healthcare | Pharmaceuticals | KRW 1.26T | 6.4x | 0.16 | KRW 94,600 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
HK Inno.N | KOSDAQ | Healthcare | Pharmaceuticals | KRW 1.1T | 25.6x | KRW 37,950 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
HLB Therapeutics | KOSDAQ | Healthcare | Pharmaceuticals | KRW 1.09T | -36x | 0.08 | KRW 14,000 | 2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Oscotec | KOSDAQ | Healthcare | Pharmaceuticals | KRW 1T | -191.4x | -2.62 | KRW 25,750 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Mezzion Pharma | KOSDAQ | Healthcare | Pharmaceuticals | KRW 928.86B | -68.1x | -1.43 | KRW 30,350 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Daewoong | Seoul | Healthcare | Pharmaceuticals | KRW 901.64B | 7.1x | 3.01 | KRW 21,450 | -2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27% Upside | Upgrade to Pro+ | |
Boryung Pharm | Seoul | Healthcare | Pharmaceuticals | KRW 890.01B | 10.5x | 0.09 | KRW 10,550 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 41.5% Upside | Upgrade to Pro+ | |
Medy-Tox | KOSDAQ | Healthcare | Pharmaceuticals | KRW 836.03B | 78.8x | 5.2 | KRW 124,900 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Green Cross Holdings | Seoul | Healthcare | Pharmaceuticals | KRW 737.89B | -11.2x | 0.01 | KRW 23,800 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Green Cross | Seoul | Healthcare | Pharmaceuticals | KRW 737.89B | -11.2x | 0.01 | KRW 16,100 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Dongkook Pharmaceutical | KOSDAQ | Healthcare | Pharmaceuticals | KRW 702.61B | 12.1x | 0.39 | KRW 15,860 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 43.9% Upside | Upgrade to Pro+ |